A start-up that aims to discover new drugs for incurable illnesses is now worth $2 billion after funding
April 19, 2018 at 06:48 AM EDT
BenevolentAI said the latest round of funding will help it scale drug development and its AI platform.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|